246 related articles for article (PubMed ID: 15571232)
1. Deoxyribonucleoside kinases in mitochondrial DNA depletion.
Saada-Reisch A
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1205-15. PubMed ID: 15571232
[TBL] [Abstract][Full Text] [Related]
2. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy.
Saada A; Shaag A; Mandel H; Nevo Y; Eriksson S; Elpeleg O
Nat Genet; 2001 Nov; 29(3):342-4. PubMed ID: 11687801
[TBL] [Abstract][Full Text] [Related]
3. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA.
Mandel H; Szargel R; Labay V; Elpeleg O; Saada A; Shalata A; Anbinder Y; Berkowitz D; Hartman C; Barak M; Eriksson S; Cohen N
Nat Genet; 2001 Nov; 29(3):337-41. PubMed ID: 11687800
[TBL] [Abstract][Full Text] [Related]
4. Depletion of the other genome-mitochondrial DNA depletion syndromes in humans.
Elpeleg O; Mandel H; Saada A
J Mol Med (Berl); 2002 Jul; 80(7):389-96. PubMed ID: 12110944
[TBL] [Abstract][Full Text] [Related]
5. Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes.
Wang L; Limongelli A; Vila MR; Carrara F; Zeviani M; Eriksson S
Mol Genet Metab; 2005 Jan; 84(1):75-82. PubMed ID: 15639197
[TBL] [Abstract][Full Text] [Related]
6. Tissue specific distribution of pyrimidine deoxynucleoside salvage enzymes shed light on the mechanism of mitochondrial DNA depletion.
Wang L; Eriksson S
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):400-3. PubMed ID: 20544526
[TBL] [Abstract][Full Text] [Related]
7. Deoxynucleoside salvage enzymes and tissue specific mitochondrial DNA depletion.
Wang L
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):370-81. PubMed ID: 20544522
[TBL] [Abstract][Full Text] [Related]
8. Activity profiles of deoxynucleoside kinases and 5'-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs.
Rylova SN; Albertioni F; Flygh G; Eriksson S
Biochem Pharmacol; 2005 Mar; 69(6):951-60. PubMed ID: 15748706
[TBL] [Abstract][Full Text] [Related]
9. Deoxyribonucleoside kinases belonging to the thymidine kinase 2 (TK2)-like group vary significantly in substrate specificity, kinetics and feed-back regulation.
Knecht W; Petersen GE; Munch-Petersen B; Piskur J
J Mol Biol; 2002 Jan; 315(4):529-40. PubMed ID: 11812127
[TBL] [Abstract][Full Text] [Related]
10. Expression of deoxynucleoside kinases and 5'-nucleotidases in mouse tissues: implications for mitochondrial toxicity.
Rylova SN; Mirzaee S; Albertioni F; Eriksson S
Biochem Pharmacol; 2007 Jun; 74(1):169-75. PubMed ID: 17493587
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene.
Mancuso M; Filosto M; Bonilla E; Hirano M; Shanske S; Vu TH; DiMauro S
Arch Neurol; 2003 Jul; 60(7):1007-9. PubMed ID: 12873860
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial deoxyribonucleotide pools in deoxyguanosine kinase deficiency.
Saada A
Mol Genet Metab; 2008 Nov; 95(3):169-73. PubMed ID: 18723380
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA.
Mancuso M; Salviati L; Sacconi S; Otaegui D; Camaño P; Marina A; Bacman S; Moraes CT; Carlo JR; Garcia M; Garcia-Alvarez M; Monzon L; Naini AB; Hirano M; Bonilla E; Taratuto AL; DiMauro S; Vu TH
Neurology; 2002 Oct; 59(8):1197-202. PubMed ID: 12391347
[TBL] [Abstract][Full Text] [Related]
14. Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene.
Chanprasert S; Wang J; Weng SW; Enns GM; Boué DR; Wong BL; Mendell JR; Perry DA; Sahenk Z; Craigen WJ; Alcala FJ; Pascual JM; Melancon S; Zhang VW; Scaglia F; Wong LJ
Mol Genet Metab; 2013; 110(1-2):153-61. PubMed ID: 23932787
[TBL] [Abstract][Full Text] [Related]
15. Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome.
Götz A; Isohanni P; Pihko H; Paetau A; Herva R; Saarenpää-Heikkilä O; Valanne L; Marjavaara S; Suomalainen A
Brain; 2008 Nov; 131(Pt 11):2841-50. PubMed ID: 18819985
[TBL] [Abstract][Full Text] [Related]
16. Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion.
Lesko N; Naess K; Wibom R; Solaroli N; Nennesmo I; von Döbeln U; Karlsson A; Larsson NG
Neuromuscul Disord; 2010 Mar; 20(3):198-203. PubMed ID: 20083405
[TBL] [Abstract][Full Text] [Related]
17. The role of mitochondrial dNTP levels in cells with reduced TK2 activity.
Desler C; Munch-Petersen B; Rasmussen LJ
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1171-5. PubMed ID: 17065084
[TBL] [Abstract][Full Text] [Related]
18. Acute cytotoxicity of arabinofuranosyl nucleoside analogs is not dependent on mitochondrial DNA.
Curbo S; Johansson M; Balzarini J; Lewis LD; Karlsson A
Exp Cell Res; 2009 Sep; 315(15):2539-43. PubMed ID: 19481540
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial thymidine kinase 2 but not deoxyguanosine kinase is up-regulated during the stationary growth phase of cultured cells.
Sun R; Eriksson S; Wang L
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):282-6. PubMed ID: 24940680
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of mitochondrial DNA depletion diseases caused by deficiencies in enzymes in purine and pyrimidine metabolism.
Eriksson S; Wang L
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):800-8. PubMed ID: 18600543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
